Kiniksa Pharmaceuticals to Present at Upcoming Investor Conferences
Kiniksa Pharmaceuticals (Nasdaq: KNSA) has announced its participation in two major investor conferences in June 2025. The company will present at the Jefferies 2025 Global Healthcare Conference on June 5 at 12:50 p.m. ET and participate in a fireside chat at the Goldman Sachs 46th Annual Global Healthcare Conference on June 10 at 8:00 a.m. ET. Both presentations will be available via live webcast through Kiniksa's website in the Investors & Media section, with replays accessible within 48 hours after each event.
[]Kiniksa Pharmaceuticals (Nasdaq: KNSA) ha annunciato la sua partecipazione a due importanti conferenze per investitori nel giugno 2025. L'azienda presenterà al Jefferies 2025 Global Healthcare Conference il 5 giugno alle 12:50 ET e parteciperà a un incontro informale al Goldman Sachs 46th Annual Global Healthcare Conference il 10 giugno alle 8:00 ET. Entrambe le presentazioni saranno disponibili in diretta streaming sul sito web di Kiniksa nella sezione Investitori & Media, con le registrazioni accessibili entro 48 ore dalla fine di ciascun evento.
Kiniksa Pharmaceuticals (Nasdaq: KNSA) ha anunciado su participación en dos importantes conferencias para inversores en junio de 2025. La compañía presentará en la Jefferies 2025 Global Healthcare Conference el 5 de junio a las 12:50 p.m. ET y participará en una charla informal en la Goldman Sachs 46th Annual Global Healthcare Conference el 10 de junio a las 8:00 a.m. ET. Ambas presentaciones estarán disponibles en transmisión en vivo a través del sitio web de Kiniksa en la sección de Inversores y Medios, con repeticiones accesibles dentro de las 48 horas posteriores a cada evento.
Kiniksa Pharmaceuticals (나스닥: KNSA)는 2025년 6월 두 개의 주요 투자자 컨퍼런스에 참여한다고 발표했습니다. 회사는 6월 5일 오후 12시 50분(동부시간) Jefferies 2025 Global Healthcare Conference에서 발표하며, 6월 10일 오전 8시(동부시간) Goldman Sachs 46th Annual Global Healthcare Conference에서 파이어사이드 채팅에 참여할 예정입니다. 두 발표 모두 Kiniksa 웹사이트의 투자자 및 미디어 섹션을 통해 생중계되며, 각 행사 종료 후 48시간 이내에 다시보기가 가능합니다.
Kiniksa Pharmaceuticals (Nasdaq : KNSA) a annoncé sa participation à deux grandes conférences pour investisseurs en juin 2025. La société présentera lors de la Jefferies 2025 Global Healthcare Conference le 5 juin à 12h50 ET et participera à une discussion informelle lors de la Goldman Sachs 46th Annual Global Healthcare Conference le 10 juin à 8h00 ET. Les deux présentations seront disponibles en direct via le site web de Kiniksa dans la section Investisseurs & Médias, avec des rediffusions accessibles dans les 48 heures suivant chaque événement.
Kiniksa Pharmaceuticals (Nasdaq: KNSA) hat seine Teilnahme an zwei bedeutenden Investorenkonferenzen im Juni 2025 angekündigt. Das Unternehmen wird am Jefferies 2025 Global Healthcare Conference am 5. Juni um 12:50 Uhr ET präsentieren und an einem Fireside-Chat auf der Goldman Sachs 46th Annual Global Healthcare Conference am 10. Juni um 8:00 Uhr ET teilnehmen. Beide Präsentationen werden live über die Website von Kiniksa im Bereich Investoren & Medien übertragen, mit Wiedergaben, die innerhalb von 48 Stunden nach jeder Veranstaltung verfügbar sind.
- None.
- None.
LONDON, May 29, 2025 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) today announced that management will present at the following investor conferences in June:
- Jefferies 2025 Global Healthcare Conference on Thursday, June 5 at 12:50 p.m. Eastern Time
- Goldman Sachs 46th Annual Global Healthcare Conference on Tuesday, June 10 at 8:00 a.m. Eastern Time – Fireside Chat
A live webcast of Kiniksa’s presentations will be accessible through the Investors & Media section of the company’s website at www.kiniksa.com. A replay of the events will also be available on Kiniksa’s website within approximately 48 hours after the event.
About Kiniksa
Kiniksa is a biopharmaceutical company dedicated to improving the lives of patients suffering from debilitating diseases by discovering, acquiring, developing, and commercializing novel therapies for diseases with unmet need, with a focus on cardiovascular indications. Kiniksa’s portfolio of assets is based on strong biologic rationale or validated mechanisms and offers the potential for differentiation. For more information, please visit www.kiniksa.com.
Every Second Counts! ®
Kiniksa Investor & Media Contact
Jonathan Kirshenbaum
(781) 829-3949
jkirshenbaum@kiniksa.com
FAQ
When is Kiniksa Pharmaceuticals (KNSA) presenting at the Jefferies Healthcare Conference 2025?
What time is KNSA's presentation at the Goldman Sachs Healthcare Conference 2025?
How can I access Kiniksa Pharmaceuticals' investor conference presentations?
Which investor conferences is KNSA attending in June 2025?
